Any grade treatment-related AEs reported in at least 10% of patients
| Adverse event | <800 mg n = 9 n (%) | 800 mg n = 24 n (%) | Total n = 33 n (%) | ||
|---|---|---|---|---|---|
| Decreased white cell count | 8 (89) | 21 (88) | 29 (88) | ||
| Lymphopenia | 9 (100) | 20 (83) | 29 (88) | ||
| Neutropenia | 5 (56) | 19 (79) | 24 (73) | ||
| Nausea | 6 (67) | 16 (67) | 22 (67) | ||
| Anemia | 5 (56) | 8 (33) | 13 (39) | ||
| Thrombocytopenia | 4 (44) | 7 (29) | 11 (33) | ||
| Vomiting | 3 (33) | 8 (33) | 11 (33) | ||
| Diarrhea | 2 (22) | 7 (29) | 9 (27) | ||
| Infection (any) | 0 (0) | 9 (38) | 9 (27) | ||
| Fatigue | 1 (33) | 5 (21) | 6 (18) | ||
| Lethargy | 0 (0) | 4 (17) | 4 (12) | ||
| Pruritis | 0 (0) | 4 (17) | 4 (12) | ||
| Rash | 1 (33) | 3 (13) | 4 (12) |